Sigilon Therapeutics: Jumps more than 22% in Nasdaq debut
** Sigilon Therapeutics Inc's shares SGTX.O jump more than
22% to $22 in their market debut
** Co had priced IPO at $18 per share urn:newsml:reuters.com:*:nGNX4D4z53
** Co offered 7 mln shares in IPO, raising about $154 mln
** Morgan Stanley, Jefferies, Barclays and Canaccord Genuity
are the lead underwriters for the offering
(Reporting by Sohini Podder in Bengaluru)
((Sohini.Podder@thomsonreuters.com;))
Recent news on Sigilon Therapeutics
See all newsSigilon Therapeutics Inc reports results for the quarter ended in June - Earnings Summary
Sigilon Therapeutics Inc expected to post a loss of $4.71 a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Micron, Greenbrier, Immunome
Sigilon jumps on Eli Lilly's buyout deal to expand diabetes treatments
U.S. STOCKS ON THE MOVE-Sigilon, Netflix, RenovoRx